Sumitomo Mitsui Trust Holdings, Inc. Gilead Sciences, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 3,302,290 shares of GILD stock, worth $389 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,302,290
Previous 3,091,193
6.83%
Holding current value
$389 Million
Previous $346 Million
5.7%
% of portfolio
0.23%
Previous 0.25%
Shares
33 transactions
Others Institutions Holding GILD
# of Institutions
2,328Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.98 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.46 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.42 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...